Dual-Confined engineering boosts Cas12a efficiency for precise single exosome-based breast cancer diagnosis

Quick Facts

• Publication title: Dual-Confined engineering boosts Cas12a efficiency for precise single exosome-based breast cancer diagnosis
• Journal: Chem Eng J
• Year: 2025
• DOI: 10.1016/j.cej.2025.164318

Research overview

This peer-reviewed publication presents research in Oncology and EV Biology & Disease Mechanisms. Its research topic is reflected in the title: "Dual-Confined engineering boosts Cas12a efficiency for precise single exosome-based breast cancer diagnosis."

Echo Biotech Role

Echo Biotech contributed exosome-depleted media supply; the study also used or cited ExoCCM®.

Related platforms: Research Reagents & Tools

Related services and capabilities: Exosome-Depleted Serum / Medium Supply

Related products or reagents: ExoCCM® Exosome-Depleted Serum/Medium

References

Original publication: Dual-Confined engineering boosts Cas12a efficiency for precise single exosome-based breast cancer diagnosis Chemical Engineering Journal. 2025. DOI: 10.1016/j.cej.2025.164318.